Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya

MLA

Yonas Abebe, et al. “Safety, Tolerability, and Immunogenicity of Plasmodium Falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-Escalation, Dose-Escalation, Double-Blind, Randomized Controlled Study in Western Kenya.” Clinical Infectious Diseases, vol. 71, Sept. 2019, pp. 1063–71. EBSCOhost, https://doi.org/10.1093/cid/ciz925.

APA

Yonas Abebe, Mary J. Hamel, Kephas Otieno, Aaron M. Samuels, Martina Oneko, Laura C. Steinhardt, Simon Kariuki, S. Patrick Kachur, David Styers, Stephen L. Hoffman, Natasha Kc, Allan Dungani, L. W. Preston Church, Eric R. James, Reuben Yego, Tony Sang, Dorcas Akach, Ryan E. Wiegand, Ginnie Abarbanell, … Tooba Murshedkar. (2019). Safety, Tolerability, and Immunogenicity of Plasmodium falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-escalation, Dose-Escalation, Double-blind, Randomized Controlled Study in Western Kenya. Clinical Infectious Diseases, 71, 1063–1071. https://doi.org/10.1093/cid/ciz925

Chicago

Yonas Abebe, Mary J. Hamel, Kephas Otieno, Aaron M. Samuels, Martina Oneko, Laura C. Steinhardt, Simon Kariuki, et al. 2019. “Safety, Tolerability, and Immunogenicity of Plasmodium Falciparum Sporozoite Vaccine Administered by Direct Venous Inoculation to Infants and Young Children: Findings From an Age De-Escalation, Dose-Escalation, Double-Blind, Randomized Controlled Study in Western Kenya.” Clinical Infectious Diseases 71 (September): 1063–71. doi:10.1093/cid/ciz925.